Blood redox status is associated with the likelihood of nonalcoholic fatty liver disease irrespectively of diet's total antioxidant capacity

Nutrition Research

Volumn 35, Issue 1, 2015, Pages 41-48

  Georgoulis, Michael ^a   Fragopoulou, Elisabeth ^a   Kontogianni, Meropi D ^a   Margariti, Aikaterini ^b   Boulamatsi, Olga ^a   Detopoulou, Paraskeui ^a   Tiniakos, Dina ^b   Zafiropoulou, Rodessa ^b   Papatheodoridis, George ^b  

^a HAROKOPIO UNIVERSITY   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Dietary antioxidant potential; Nonalcoholic liver steatosis; Nonalcoholic steatohepatitis; Oxidative stress; Redox status

Indexed keywords

ADIPONECTIN; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; ALANINE AMINOTRANSFERASE; ANTIOXIDANT; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE;

ABDOMINAL FAT; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; INSULIN RESISTANCE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; NUTRITIONAL PARAMETERS; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; SMOKING; TOTAL ANTIOXIDANT CAPACITY; WAIST CIRCUMFERENCE; BLOOD; CHEMISTRY; CROSS-SECTIONAL STUDY; DIET; METABOLISM; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; STATISTICAL MODEL;

ADULT; ALANINE TRANSAMINASE; ANTIOXIDANTS; BIOLOGICAL MARKERS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIET; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE PEROXIDASE; HUMANS; INSULIN RESISTANCE; LIPID PEROXIDATION; LOGISTIC MODELS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; WAIST CIRCUMFERENCE;

EID: 84920864417     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2014.11.004     Document Type: Article

References (46)

1. Vernon G., Baranova A., Younossi Z.M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011, 34:274-285.
2. Levene A.P., Goldin R.D. The epidemiology, pathogenesis and histopathology of fatty liver disease. Histopathology 2012, 61:141-152.
3. Day C.P., James O.F. Steatohepatitis: a tale of two "hits"?. Gastroenterology 1998, 114:842-845.
4. Rolo A.P., Teodoro J.S., Palmeira C.M. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med 2012, 52:59-69.
5. Day C.P. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 2002, 16:663-678.
6. Estep J.M., Baranova A., Hossain N., Elariny H., Ankrah K., Afendy A., et al. Expression of cytokine signaling genes in morbidly obese patients with non-alcoholic steatohepatitis and hepatic fibrosis. Obes Surg 2009, 19:617-624.
7. Koek G.H., Liedorp P.R., Bast A. The role of oxidative stress in non-alcoholic steatohepatitis. Clin Chim Acta 2011, 412:1297-1305.
8. Musso G., Gambino R., De Michieli F., Biroli G., Premoli A., Pagano G., et al. Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake. Am J Clin Nutr 2007, 86:661-671.
9. Hashemi Kani A., Alavian S.M., Esmaillzadeh A., Adibi P., Azadbakht L. Dietary quality indices and biochemical parameters among patients with non alcoholic fatty liver disease (NAFLD). Hepat Mon 2013, 13:e10943.
10. Georgoulis M., Kontogianni M.D., Tileli N., Margariti A., Fragopoulou E., Tiniakos D., et al. The impact of cereal grain consumption on the development and severity of non-alcoholic fatty liver disease. Eur J Nutr 2014, 53:1727-1735.
11. Kontogianni M.D., Tileli N., Margariti A., Georgoulis M., Deutsch M., Tiniakos D., et al. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr 2014, 33:678-683.
12. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999, 94:2467-2474.
13. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
14. Goulet J., Nadeau G., Lapointe A., Lamarche B., Lemieux S. Validity and reproducibility of an interviewer-administered food frequency questionnaire for healthy French-Canadian men and women. Nutr J 2004, 3:13.
15. Panagiotakos D.B., Pitsavos C., Arvaniti F., Stefanadis C. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. Prev Med 2007, 44:335-340.
16. Pellegrini N., Serafini M., Colombi B., Del Rio D., Salvatore S., Bianchi M., et al. Total antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three different in vitro assays. J Nutr 2003, 133:2812-2819.
17. Pellegrini N., Serafini M., Salvatore S., Del Rio D., Bianchi M., Brighenti F. Total antioxidant capacity of spices, dried fruits, nuts, pulses, cereals and sweets consumed in Italy assessed by three different in vitro assays. Mol Nutr Food Res 2006, 50:1030-1038.
18. Carlsen M.H., Halvorsen B.L., Holte K., Bohn S.K., Dragland S., Sampson L., et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J 2010, 9:3.
19. Benzie I.F., Strain J.J. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 1999, 299:15-27.
20. Ghiselli A., Serafini M., Maiani G., Azzini E., Ferro-Luzzi A. A fluorescence-based method for measuring total plasma antioxidant capability. Free Radic Biol Med 1995, 18:29-36.
21. Re R., Pellegrini N., Proteggente A., Pannala A., Yang M., Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 1999, 26:1231-1237.
22. Jentzsch A.M., Bachmann H., Furst P., Biesalski H.K. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 1996, 20:251-256.
23. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158-169.
24. Schnitzer E., Pinchuk I., Bor A., Fainaru M., Samuni A.M., Lichtenberg D. Lipid oxidation in unfractionated serum and plasma. Chem Phys Lipids 1998, 92:151-170.
25. Mouzaki M., Allard J.P. The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease. J Clin Gastroenterol 2012, 46:457-467.
26. Zelber-Sagi S., Ratziu V., Oren R. Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 2011, 17:3377-3389.
27. Cortez-Pinto H., Jesus L., Barros H., Lopes C., Moura M.C., Camilo M.E. How different is the dietary pattern in non-alcoholic steatohepatitis patients?. Clin Nutr 2006, 25:816-823.
28. Valtuena S., Pellegrini N., Franzini L., Bianchi M.A., Ardigo D., Del Rio D., et al. Food selection based on total antioxidant capacity can modify antioxidant intake, systemic inflammation, and liver function without altering markers of oxidative stress. Am J Clin Nutr 2008, 87:1290-1297.
29. Pellegrini N., Salvatore S., Valtuena S., Bedogni G., Porrini M., Pala V., et al. Development and validation of a food frequency questionnaire for the assessment of dietary total antioxidant capacity. J Nutr 2007, 137:93-98.
30. Serafini M., Del Rio D. Understanding the association between dietary antioxidants, redox status and disease: is the Total Antioxidant Capacity the right tool?. Redox Rep 2004, 9:145-152.
31. Das K.S., Balakrishnan V., Mukherjee S., Vasudevan D.M. Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease. Scand J Clin Lab Invest 2008, 68:323-334.
32. Madan K., Bhardwaj P., Thareja S., Gupta S.D., Saraya A. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol 2006, 40:930-935.
33. Narasimhan S., Gokulakrishnan K., Sampathkumar R., Farooq S., Ravikumar R., Mohan V., et al. Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. Clin Biochem 2010, 43:815-821.
34. Sandhya N., Gokulakrishnan K., Ravikumar R., Mohan V., Balasubramanyam M. Association of hypoadiponectinemia with hypoglutathionemia in NAFLD subjects with and without type 2 diabetes. Dis Markers 2010, 29:213-221.
35. Uysal S., Armutcu F., Aydogan T., Akin K., Ikizek M., Yigitoglu M.R. Some inflammatory cytokine levels, iron metabolism and oxidan stress markers in subjects with nonalcoholic steatohepatitis. Clin Biochem 2011, 44:1375-1379.
36. Loguercio C., De Girolamo V., de Sio I., Tuccillo C., Ascione A., Baldi F., et al. Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol 2001, 35:568-574.
37. Machado M.V., Ravasco P., Jesus L., Marques-Vidal P., Oliveira C.R., Proenca T., et al. Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet. Scand J Gastroenterol 2008, 43:95-102.
38. Nobili V., Pastore A., Gaeta L.M., Tozzi G., Comparcola D., Sartorelli M.R., et al. Glutathione metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis. Clin Chim Acta 2005, 355:105-111.
39. Koruk M., Taysi S., Savas M.C., Yilmaz O., Akcay F., Karakok M. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Ann Clin Lab Sci 2004, 34:57-62.
40. Samy W., Hassanian M.A. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin. Arab J Gastroenterol 2011, 12:80-85.
41. Chalasani N., Deeg M.A., Crabb D.W. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004, 99:1497-1502.
42. Gambino R., Cassader M., Pagano G., Durazzo M., Musso G. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH?. Hepatology 2007, 45:1097-1107.
43. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
44. Videla L.A., Rodrigo R., Araya J., Poniachik J. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. Trends Mol Med 2006, 12:555-558.
45. Miglio C., Chiavaro E., Visconti A., Fogliano V., Pellegrini N. Effects of different cooking methods on nutritional and physicochemical characteristics of selected vegetables. J Agric Food Chem 2008, 56:139-147.
46. Bonnefont-Rousselot D., Ratziu V., Giral P., Charlotte F., Beucler I., Poynard T., et al. Blood oxidative stress markers are unreliable markers of hepatic steatosis. Aliment Pharmacol Ther 2006, 23:91-98.